Patents Assigned to Neuprozyme Therapeutics APS
  • Patent number: 10479781
    Abstract: The invention relates to compounds of Formula (I) and their use as selective dipeptidyl peptidase I inhibitors, as well as pharmaceutical compositions comprising said compounds, and methods of treatment involving said compounds.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: November 19, 2019
    Assignee: Neuprozyme Therapeutics APS
    Inventors: Conni Lauritzen, John Pedersen